Janssen’s psoriasis drug shows promise for childhood diabetes
Type 1 diabetes accounts for approximately 10% of diabetes cases in the UK
Read More
Author: Jen Brogan
Researchers reveal brain parasites could be used to treat cognitive disorders
Neurological conditions, including Alzheimer’s disease, are the leading cause of ill health globally
Read More
BHF’s HIF funds five heart research projects over £800,000
Cardiovascular diseases currently affect around seven million people in the UK, including coronary heart disease
Read More
New study reveals certain bacteria are toxic for head and neck cancer
Head and neck cancer is currently recognised as the sixth most common cancer globally
Read More
ETH Zurich researchers reveal how colorectal cancer cells colonise the liver
Bowel cancer, the third most common cancer type worldwide, is the second most common cause of cancer death
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
